Efficacy of β-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 3, 1999, Pages 367-371

  Tateda, Kazuhiro ^a   Matsumoto, Tetsuya ^a   Miyazaki, Shuichi ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; GENTAMICIN; IMIPENEM; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; LOBAR PNEUMONIA; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; GENTAMICINS; MALE; MICE; MICE, INBRED CBA; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0033036841     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Macfarlane, J. T., Finch, R. G., Ward, M. J. & Macrae, A. D. (1982). Hospital study of adult community-acquired pneumonia. Lancet ii, 255-8.
2. Austrian, R. (1986). Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations. Chest 90, 738-43.
3. Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J. & the Pneumococcal Surveillance Working Group. (1991). Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. Journal of Infectious Diseases 163, 1273-78.
4. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
5. Caputo, G. M., Appelbaum, P. C. & Liu, H. H. (1993). Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Archives of Internal Medicine 153, 1301-10.
6. Bradley, J. S. & Connor, J. D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatric Infectious Disease Journal 10, 871-3.
7. Canton, E. (1992). Cefotaxime breakpoint for Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 37, 616-7.
8. John, C. C. (1994). Treatment failure with use of third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clinical Infectious Diseases 18, 188-93.
9. McCracken, G. H. & Sakata, Y. (1985). Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 27, 141-5.
10. Barakett, V., Lesage, D., Delisle, F., Richard, G. & Petit, J. C. (1994). Killing kinetics of imipenem against penicillin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 33, 1025-8.
11. Friedland, I. R., Paris, M., Shelton, S. & McCracken, G. H. (1994). Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 34, 231-7.
12. Doit, C. P., Bonacorsi, S. P., Fremaux, A. J., Sissia, G., Cohen, R., Geslin, P. L. et al. (1994). In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated form children with meningitis. Antimicrobial Agents and Chemotherapy 38, 2655-9.
13. Schlegel, L., Sissia, G., Fremaux, A. & Geslin, P. (1997). In-vitro killing activity of combinations of β-lactam agents with aminoglycosides against penicillin-resistant pneumococci. Journal of Antimicrobial Chemotherapy 39, 95-8.
14. Darras-Joly, C., Bedos, J. P., Sauve, C., Moine, P., Vallee, E., Carbon, C. et al. (1996). Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrobial Agents and Chemotherapy 40, 2147-51.
15. Feldman, C., Kallenbach, J. M., Miller, S. D., Thorburn, J. R. & Koornhof, H. J. (1985). Community-acquired pneumonia due to penicillin-resistant pneumococci. New England Journal of Medicine 313, 615-7.
16. Woodhead, M. A., Macfarlane, J. T., McCracken, J. S., Rose, D. H. & Finch, R. G. (1987). Prospective study of the aetiology and outcome of pneumonia in the community. Lancet i, 671-4.
17. Takashima, K., Tateda, K., Matsumoto, T., lizawa, Y., Nakao, M. & Yamaguchi, K. (1996). Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice. Journal of Medical Microbiology 45, 319-22.
18. Tateda, K., Takashima, K., Miyazaki, H., Matsumoto, T., Hatori, T. & Yamaguchi, K. (1996). Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrobial Agents and Chemotherapy 40, 1520-5.
19. Gross, M. E., Giron, K. P., Septimus, J. D., Mason, E. O. & Musher, D. M. (1995). Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrobial Agents and Chemotherapy 39, 1166-8.
20. Chung, M., Costello, R. & Symchowicz, S. (1980). Comparison of netilmicin and gentamicin pharmacokinetics in humans. Antimicrobial Agents and Chemotherapy 17, 184-7.
21. Martinez, F., Martin-Luengo, F., Garcia, A. & Valdes, M. (1994). Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis. Journal of Antimicrobial Chemotherapy 33, 1201-7.